Search clinical trials for: mild asthma

Total 12584 results

Yuhan Corporation

Completed

A FIH Study of YH35324 in Atopic Healthy Subjects or Subjects With Mild Allergic Diseases

Atopic Healthy Subjects | Adult Subjects With Mild Allergic Diseases

Korea, Republic of
Aldeyra Therapeutics, Inc.

Completed

A Double Masked, Placebo Controlled, Single Center, Randomized Clinical Trial to Assess the Safety and Efficacy of Subjects With Mild Asthma Induced by the Bronchial Allergen Challenge (BAC)

Atopic Asthma

Canada
Genentech, Inc.

Completed

A Study of Omalizumab in the Prevention of Allergen Induced Airway Obstruction in Adults With Mild Allergic Asthma (AQUA)

Allergic Asthma
Chiesi Farmaceutici S.p.A.

Completed

A Study to Compare the Effects of Two Propellants in Adults With Mild Asthma

Asthma

United Kingdom
Massachusetts General Hospital
University of Alabama at Birmingham

Active, not recruiting

Nitric Oxide Gas Inhalation Therapy for Mild/Moderate COVID-19 (NoCovid)

Coronavirus Infections | Pneumonia, Viral | Acute Respiratory Distress Syndrome

United States
Sanotize Research and Development corp.
Glenmark Pharmaceuticals Ltd. India

Completed

Nitric Oxide Nasal Spray (NONS) To Treat and Prevent the Exacerbation of Infection in Individuals With Mild COVID-19

SARS-CoV-2 Infection

India
Amgen

Completed

Double-blind, Multiple Dose Study of Tezepelumab (AMG 157) in Adults With Mild Atopic Asthma

Asthma

Canada
Evelo Biosciences, Inc.

Completed

Study in Healthy Participants and Participants With Moderate Atopic Dermatitis & Optionally, Moderate Psoriasis, and/or Mild Asthma

Psoriasis | Asthma | Atopic Dermatitis

United Kingdom
Chiesi Farmaceutici S.p.A.

Completed

Study on Patterns of Care in Mild Asthmatic Patients (PRIME)

Asthma

Germany, Italy, Poland, Spain
University of Saskatchewan

Completed

Regular Use Tiotropium and Tolerance to Bronchoprotection in Mild Asthma

Asthma

Canada
University of Campinas, Brazil
Texas Tech University

Completed

Microneedle Pretreatment as a Strategy to Improve the Effectiveness of Topical Anesthetics Formulations

Oral Cavity Disease

Brazil
Organon and Co

Completed

A Study to Evaluate MK0476 and Fluticasone to Control Asthma in Patients With Mild Persistent Asthma (0476-910)

Asthma, Bronchial
Organon and Co

Completed

A Study to Compare Effectiveness of Montelukast Sodium With Comparator in Mild to Moderate Persistent Asthmatics (0476-329)

Asthma | Allergic Rhinitis
MEDA Pharma GmbH & Co. KG

Completed

5-Year Safety Study of Pimecrolimus Cream 1% in Infants 3 - 12 Months of Age With Mild to Moderate Atopic Dermatitis

Atopic Dermatitis

United States, Germany
Organon and Co

Terminated

Efficacy and Tolerability of Maintenance Treatment With Asmanex Twisthaler Versus Placebo in Mild/Moderate Persistent Asthmatics (Study P04654)(TERMINATED)

Asthma
T-Balance Therapeutics GmbH

Completed

Effects of Tregalizumab on Allergen-induced Airway Responses and Airway Inflammation in Asthmatic Patients (Tregulaire)

Allergic Asthma | Allergy to House Dust Mite

Germany
Pfizer

Completed

A Study to Evaluate Long-Term Maintenance Treatment With Once Daily Crisaborole Ointment 2% in Pediatric and Adult Participants With Mild-to-Moderate Atopic Dermatitis

Atopic Dermatitis

China, United States, Turkey, Australia, Canada, Israel
Intech Biopharm Ltd.
Peking University People's Hospital; Beijing Friendship Hospital; The Second... and other collaborators

Completed

Clinical Equivalence of Budesonide HFA MDI Versus Budesonide Turbuhaler in Mild to Moderate Chinese Asthma Patients

Asthma

China
Teva Branded Pharmaceutical Products R&D, Inc.
AllerGen NCE Inc.

Completed

Efficacy/Safety Study of Nebulized IVX-0142, a Novel Antiallergic Drug, in Mild Allergic Asthma

Asthma

Canada
AZTherapies, Inc.

Terminated

A Safety and Biomarker Study of ALZT-OP1a in Subjects With Mild-Moderate ALS Disease

Amyotrophic Lateral Sclerosis

United States
Chiesi Farmaceutici S.p.A.

Completed

Dose Response AMP Challenge Study With Beclometasone Dipropionate (BDP)/Formoterol Pressurised Metered Dose Inhaler (pMDI)

Mild Persistent Asthma

United Kingdom
Novartis Pharmaceuticals

Completed

A Bronchoprovocation Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of CSJ117 in Adult Subjects With Mild Atopic Asthma

Asthma

Germany, Canada
Novartis Pharmaceuticals

Completed

Study of QMF149 (150/80 µg) Compared With MF Twisthaler® (200 µg) in Patients With Asthma

Mild Asthma

Germany, India, Korea, Republic of, Poland, South Africa, Estonia, Italy, Russian Federation, Thailand, Latvia, Lithuania, Colombia, Hungary, Peru, Philippines, Slovakia, Bulgaria, Vietnam, Japan, Malaysia, Chile, Sweden
Rush University Medical Center

Withdrawn

The Impact of the Routine Aminophylline Administration Following Regadenoson Stress on SPECT Myocardial Perfusion (ASSUAGE-MPI)

Coronary Artery Disease

United States
Dasman Diabetes Institute

Completed

Breathing & Mild Physical Exercise Therapy for Asthma

Asthma

Kuwait
Sanotize Research and Development corp.

Withdrawn

Nitric Oxide Releasing Solution to Treat and Prevent Exacerbation of Mild COVID-19 Infection

SARS-CoV Infection
Regeneron Pharmaceuticals

Completed

Study in Cat-Allergic Patients With Asthma to Evaluate the Efficacy of a Single Dose of REGN1908-1909 to Reduce Bronchoconstriction Upon Cat Allergen Challenge

Cat Allergy | Mild Asthma

France
AstraZeneca

Completed

A Study in Healthy Volunteers and Patients With Mild Asthma to Investigate the Safety, Anti-inflammatory Effect of Inhaled AZD0449

Asthma

New Zealand, United Kingdom
Pfizer

Completed

Dose Ranging Study to Assess Efficacy, Safety, Tolerability and Pharmacokinetics of PF-06700841 Topical Cream in Participants With Mild or Moderate Atopic Dermatitis

Atopic Dermatitis

Germany, United States, Canada, Denmark, Hungary, Australia, Latvia, Poland, Bulgaria, Japan
SecuraBio

Completed

A Phase 2a, Efficacy and Safety Study of Duvelisib in Mild Asthmatic Subjects

Asthma

Germany, United Kingdom
Karolinska Institutet
Imperial College London; Jagiellonian University; Università degli Studi di Ferrara and other collaborators

Active, not recruiting

Longitudinal Assessment of Clinical Course and BIOmarkers in Severe Chronic AIRway Disease (BIOAIR)

Asthma | COPD

Sweden
GlaxoSmithKline

Completed

First Time in Human (FTIH) Study to Evaluate Safety, Tolerability, Immunogenicity, Pharmacokinetics (PK) and Pharmacodynamics (PD) of GSK3511294 Administered Subcutaneously (SC) in Subjects With Mild to Moderate Asthma

Asthma

United Kingdom, Germany
Sanotize Research and Development corp.
The Emmes Company, LLC; Keyrus Life Science

Completed

Nitric Oxide Releasing Solutions to Prevent and Treat Mild/Moderate COVID-19 Infection (NOCOVID)

Corona Virus Infection

Canada
AstraZeneca

Completed

Study to Evaluate the Effect of Benralizumab on Allergen-Induced Inflammation in Mild, Atopic Asthmatics (ARIA)

Asthma

Canada
Pieris Australia Pty Ltd

Completed

Study of Multiple Doses of PRS-060 Administered by Oral Inhalation in Subjects With Mild Asthma

Asthma

Australia
Novartis Pharmaceuticals

Terminated

Efficacy, Safety and Pharmacokinetics of QAV680 Versus Placebo in Patients With Asthma

Asthma

Germany, Russian Federation, United States
Novartis

Completed

Tolerability of Indacaterol Salts (Maleate, Xinafoate and Acetate) in Comparison to Placebo in Patients With Mild to Moderate Persistent Asthma

Asthma

Canada
Lupin, Inc.

Completed

Pharmacodynamic Bioequivalence of Metered Dose Inhalers of Albuterol Sulfate in Patients With Stable Mild Asthma

Mild Persistent Asthma

United States
National Cerebral and Cardiovascular Center

Completed

A Trial of Cilostazol in Patients With Mild Cognitive Impairment (COMCID)

Mild Cognitive Impairment

Japan
Laval University
GlaxoSmithKline

Unknown

Follow-up of Mild Eosinophilic Asthma

Asthma

Canada
West Penn Allegheny Health System

Completed

Effect of Flovent Discus vs QVAR vs Pulmicort Flexhaler on Short Term Growth

Asthma

United States
West Penn Allegheny Health System

Completed

Sunovion Growth Study Pediatric Subjects With Mild Asthma & Allergic Rhinitis

Asthma | Allergic Rhinitis

United States
AstraZeneca
Parexel

Withdrawn

A Study to Evaluate the Effect of AZD8154 Administered Via Nebulizer Once Daily in Subjects With Mild Allergic Asthma Challenged With an Inhaled Allergen

Asthma

Canada
General Innovations and Goods, Inc.
National Institute of Allergy and Infectious Diseases (NIAID); University of... and other collaborators

Completed

Investigate the Effect of the CREON2000A on Asthma Control in Children With Mild to Moderate Persistent Asthma (CREON2000A)

Asthma

United States
Eisai Co., Ltd.

Completed

A Study of E6011 in Japanese Subjects With Rheumatoid Arthritis

Arthritis, Rheumatoid

Japan
Chiesi Farmaceutici S.p.A.

Completed

As Needed Beclomethasone/Salbutamol Combination in Single Inhaler for Mild Persistent Asthma

Asthma

Spain, Austria, Italy, Poland
Palobiofarma SL
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau; Hospital...

Completed

A Study to Assess the Efficacy of a 5-day, 10- mg PBF-680 Oral Administration on Late Asthmatic Responses (LAR) in Mild to Moderate Asthmatic Patients.

Asthma

Spain
Pfizer

Completed

Safety, Tolerability And Efficacy Study Of Topical PF-06763809 In Subjects With Mild To Moderate Chronic Plaque Psoriasis

Psoriasis

Germany
Ferring Pharmaceuticals

Completed

To Evaluate the Efficacy and Safety of FE 999315 in Japanese Subjects With Mild to Moderate Active Ulcerative Colitis

Colitis, Ulcerative

Japan
Actavis Inc.

Completed

Study of Equivalence of Generic Pimecrolimus Cream 1% and Elidel® 1% in Subjects With Mild to Moderate Atopic Dermatitis

Atopic Dermatitis

United States

3

Subscribe